Outcomes of the Tryton‐dedicated bifurcation stent for the treatment of true coronary bifurcations: Individual‐patient‐data pooled analysis

Konigstein, Maayan; Srdanovic, Iva; Gore, Ankita; Rahim, Hussein; Généreux, Philippe; Ben‐Yehuda, Ori; Kumsārs, Indulis; Lesiak, Maciej; Kini, Annapoorna; Fontos, Géza; Slagboom, Ton; Ungi, Imre; Metzger, D. Christopher; Crowley, Aaron; Leon, Martin B.; Ali, Ziad A.

doi:10.1002/ccd.27952

Cited by 3 publications

(2 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Dedicated bifurcation stents were proposed as one of the resolutions to these issues [ 3 ]. However, few of them have been tested in large randomized clinical trials [ 4 , 5 ].…”

Section: Introductionmentioning

confidence: 99%

Twelve-month clinical results from the new cobalt-chromium sirolimus-eluting dedicated bifurcation stent BiOSS LIM C Registry

et al. 2020

View full text Add to dashboard Cite

Introduction: Percutaneous coronary interventions (PCI) in bifurcations are still challenging and are associated with higher risks of periprocedural complications as well as restenosis and stent thrombosis. The aim of this paper was to summarize 12 months of clinical results of the prospective, first-inman registry assessing the BiOSS LIM C stent (Balton, Poland). Material and methods: In the prospective two-center registry we enrolled patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) and stable coronary artery disease. Provisional T-stenting was the default treatment strategy. The primary endpoint was defined as the rate of cardiac death, myocardial infarction (MI) and clinically driven target lesion revascularization (TLR) in 12-month follow-up. Results: The study population consisted of 95 patients (mean age 66.8 ±9.8 years, 17.9% were females). A BiOSS LIM C stent was implanted in the left main (LM) in 53 (55.8%) cases. There were 25.2% of patients with NSTE-ACS, 33.7% with diabetes, 90.5% with hypertension, and 53.7% had previous MI. The device success rate was 100%. An additional regular drug-eluting stent was deployed in the side branch in 18.9% of cases. Proximal optimization technique and final kissing balloon (FKB) technique were used in 53.7% and 30.5% of cases, respectively. MI type 4a was registered in four cases (4.2%). At 12 months the MACE rate was 9.5%, cardiac death 1.1%, MI 2.1% and clinically driven TLR 6.3%. All incidents, apart from one TLR, appeared in the LM subgroup. Conclusions: Our registry might suggest that PCI using the BiOSS LIM C in coronary bifurcations is feasible and might be an option for percutaneous revascularization.

show abstract

“…Dedicated bifurcation stents were proposed as one of the resolutions to these issues [ 3 ]. However, few of them have been tested in large randomized clinical trials [ 4 , 5 ].…”

Section: Introductionmentioning

confidence: 99%

Twelve-month clinical results from the new cobalt-chromium sirolimus-eluting dedicated bifurcation stent BiOSS LIM C Registry

et al. 2020

View full text Add to dashboard Cite

show abstract

“…This stent is implanted in the SB, and a DES is implanted in the MV through the open struts of this dedicated stent. A pooled analysis of the Tryton pivotal randomized controlled trial and post-approval confirmatory study comparing this stent with the PST with a DES showed that the Tryton stent was clinically non-inferior to the PST with good angiographic outcomes at 1 year[ 148 ].…”

Section: Dedicated Bifurcation Stentsmentioning

confidence: 99%

Fundamentals of percutaneous coronary bifurcation interventions

Kırat¹

2022

WJC

View full text Add to dashboard Cite

Coronary bifurcation lesions (CBLs) account for 15%-20% of all percutaneous coronary interventions. The complex nature of these lesions is responsible for poorer procedural, early and late outcomes. This complex lesion subset has received great attention in the interventional cardiac community, and multiple stenting techniques have been developed. Of these, the provisional stenting technique is most often the default strategy; however, the elective double stenting (EDS) technique is preferred in certain subsets of complex CBLs. The double kissing crush technique may be the preferred EDS technique because of its efficacy and safety in comparative trials; however, this technique consists of many steps and requires training. Many new methods have recently been added to the EDS techniques to provide better stent scaffolding and to reduce early and late adverse outcomes. Intravascular imaging is necessary to determine the interventional strategy and postinterventional results. This review discusses the basic concepts, contemporary percutaneous interventional technical approaches, new methods, and controversial treatment issues of CBLs.

show abstract

Percutaneous Coronary Intervention for Coronary Bifurcation Lesions: Latest Evidence

Tan

Ramzy

Burgess

et al. 2020

Curr Treat Options Cardio Med

View full text Add to dashboard Cite

Outcomes of the Tryton‐dedicated bifurcation stent for the treatment of true coronary bifurcations: Individual‐patient‐data pooled analysis

Cited by 3 publications

References 33 publications

Twelve-month clinical results from the new cobalt-chromium sirolimus-eluting dedicated bifurcation stent BiOSS LIM C Registry

Twelve-month clinical results from the new cobalt-chromium sirolimus-eluting dedicated bifurcation stent BiOSS LIM C Registry

Fundamentals of percutaneous coronary bifurcation interventions

Percutaneous Coronary Intervention for Coronary Bifurcation Lesions: Latest Evidence

Contact Info

Product

Resources

About